Cargando…
DeSUMOylation of chromatin-bound proteins limits the rapid transcriptional reprogramming induced by daunorubicin in acute myeloid leukemias
Genotoxicants have been used for decades as front-line therapies against cancer on the basis of their DNA-damaging actions. However, some of their non-DNA-damaging effects are also instrumental for killing dividing cells. We report here that the anthracycline Daunorubicin (DNR), one of the main drug...
Autores principales: | Boulanger, Mathias, Aqrouq, Mays, Tempé, Denis, Kifagi, Chamseddine, Ristic, Marko, Akl, Dana, Hallal, Rawan, Carusi, Aude, Gabellier, Ludovic, de Toledo, Marion, Sigurdsson, Jon-Otti, Kaoma, Tony, Andrieu-Soler, Charlotte, Forné, Thierry, Soler, Eric, Hicheri, Yosr, Gueret, Elise, Vallar, Laurent, Olsen, Jesper V, Cartron, Guillaume, Piechaczyk, Marc, Bossis, Guillaume |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10484680/ https://www.ncbi.nlm.nih.gov/pubmed/37462077 http://dx.doi.org/10.1093/nar/gkad581 |
Ejemplares similares
-
Ubiquitin and SUMO conjugation as biomarkers of acute myeloid leukemias response to chemotherapies
por: Gâtel, Pierre, et al.
Publicado: (2020) -
The NADPH oxidase NOX2 is a marker of adverse prognosis involved in chemoresistance of acute myeloid leukemias
por: Paolillo, Rosa, et al.
Publicado: (2022) -
DNA Repair Expression Profiling to Identify High-Risk Cytogenetically Normal Acute Myeloid Leukemia and Define New Therapeutic Targets
por: Gabellier, Ludovic, et al.
Publicado: (2020) -
SUMO and Transcriptional Regulation: The Lessons of Large-Scale Proteomic, Modifomic and Genomic Studies
por: Boulanger, Mathias, et al.
Publicado: (2021) -
Cytomegalovirus Infection With Retinitis After Brentuximab Vedotin Treatment for CD30(+) Lymphoma
por: Tudesq, Jean-Jacques, et al.
Publicado: (2017)